| Men | Women | Total | |||
---|---|---|---|---|---|---|
N | SIR (95% CI) | N | SIR (95% CI) | N | SIR (95% CI) | |
Total | 52 | 0.97 (0.72–1.27) | 68 | 1.31 (1.02–1.67) | 120 | 1.14 (0.94–1.36) |
Time period | ||||||
 1990–1998 | 19 | 1.03 (0.62–1.61) | 30 | 1.70 (1.15–2.43) | 49 | 1.36 (1.01–1.80) |
 1999–2007 | 33 | 0.93 (0.64–1.32) | 38 | 1.11 (0.79–1.53) | 71 | 1.02 (0.80–1.29) |
Histological type | ||||||
 basal cell carcinoma (BCC) | 39 | 0.90 (0.64–1.22) | 52 | 1.17 (0.87–1.53) | 91 | 1.03 (0.83–1.27) |
 squamous cell carcinoma (SCC) | 12 | 1.29 (0.66–2.25) | 16 | 2.51 (1.44–1.08) | 28 | 1.78 (1.19–2.58) |
 Other | 1 | 1.34 (0.03–7.44) | 0 | 0 (0–4.64) | 1 | 0.65 (0.02–3.62) |
Approximated UV exposure (tumour location) | ||||||
 UV-exposed | 38 | 1.09 (0.77–1.49) | 54 | 1.65 (1.24–2.15) | 92 | 1.36 (1.09–1.70) |
 UV-unexposed | 10 | 0.73 (0.35–1.30) | 7 | 0.49 (0.20–1.02) | 17 | 0.61 (0.35–0.97) |
 Unknown | 4 | 0.81 (0.23–2.07) | 7 | 1.45 (0.58–2.99) | 11 | 1.13 (0.56–2.00) |